Stock BMY BRISTOL-MYERS SQUIBB COMPANY
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Bristol-Myers Squibb Company

Company Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse
Other stock markets
 04:00:02 2023-12-08 pm EST 		Intraday chart for Bristol-Myers Squibb Company 5-day change 1st Jan Change
50.31 USD +0.30% +0.42% -30.08%
Dec. 07 Global markets live: AbbVie, McDonald's, Apple, AMD, Alphabet...
Dec. 07 Are rate cuts are coming early next year?

Sales per Business

USD in Million2021Weight2022Weight Delta
Innovative Medicines
100.0 %
46,385 100.0 % 46,159 100.0 % -0.49%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
69.0 %
29,214 63.0 % 31,828 69.0 % +8.95%
International
29.2 %
-- 13,497 29.2 % -
Other
1.8 %
852 1.8 % 834 1.8 % -2.11%

Managers

Managers TitleAgeSince
Christopher Boerner CEO
 Chief Executive Officer 52 2015
Giovanni Caforio CHM
 Chairman 58 1999
David Elkins DFI
 Director of Finance/CFO 54 2019
Samit Hirawat CTO
 Chief Tech/Sci/R&D Officer - 2018
Estelle Vester-Blokland CTO
 Chief Tech/Sci/R&D Officer - -
Greg Meyers CTO
 Chief Tech/Sci/R&D Officer - -
Cari Gallman CMP
 Compliance Officer - -
Laura Hortas IRO
 Public Communications Contact - -
Zack Newman PRN
 Corporate Officer/Principal - 2013
William Perhacs PRN
 Corporate Officer/Principal - 2007

Members of the board

Members of the board TitleAgeSince
Phyllis R. Yale BRD
 Director/Board Member 65 2019
Peter Arduini BRD
 Director/Board Member 58 2016
Derica Rice BRD
 Director/Board Member 58 2020
Paula Price BRD
 Director/Board Member 61 2020
Theodore Samuels BRD
 Director/Board Member 68 2017
David Elkins DFI
 Director of Finance/CFO 54 2019
Christopher Boerner CEO
 Chief Executive Officer 52 2015
Giovanni Caforio CHM
 Chairman 58 1999
Julia Haller BRD
 Director/Board Member 68 2019
Manuel Hidalgo Medina BRD
 Director/Board Member 55 2021

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,923,757,742 2,032,788,467 ( 69.53 %) 889,000,000 ( 30.41 %) 69.53 %

Shareholders

NameEquities%Valuation
The Vanguard Group, Inc.
9.434 %
191,958,970 9.434 % 9 892 M $
JPMorgan Investment Management, Inc.
2.374 %
48,307,539 2.374 % 2 489 M $
Geode Capital Management LLC
1.768 %
35,970,407 1.768 % 1 854 M $
Capital Research & Management Co. (Global Investors)
1.677 %
34,131,378 1.677 % 1 759 M $
Capital Research & Management Co. (World Investors)
1.505 %
30,615,440 1.505 % 1 578 M $
Norges Bank Investment Management
1.280 %
26,041,643 1.280 % 1 342 M $
Fidelity Management & Research Co. LLC
1.101 %
22,403,179 1.101 % 1 154 M $
PRIMECAP Management Co.
0.9497 %
19,324,913 0.9497 % 996 M $
Dodge & Cox
0.6453 %
13,130,739 0.6453 % 677 M $
Columbia Management Investment Advisers LLC
0.5964 %
12,135,662 0.5964 % 625 M $
NameEquities%Valuation
Bram Bradesco Asset Management S/A DTVM
0.000271 %
5,521 0.000271 % 276 991 $
NameEquities%Valuation
Transcend Wealth Collective LLC
-
117,775 - 12 366 $
FourWorld Capital Management LLC
-
100,000 - 10 500 $
Maven Investment Partners US Ltd. (US)
-
67,856 - 7 125 $
G1 Execution Services LLC
-
67,840 - 7 123 $
Private Advisor Group LLC
-
15,000 - 1 575 $
Paradigm Financial Partners LLC
-
10,000 - 1 050 $
RBC Dominion Securities, Inc.
-
2,475 - 260 $
Merrill Lynch, Pierce, Fenner & Smith, Inc.
-
1,544 - 162 $
Wells Fargo Advisors Financial Network LLC
-
18 - 2 $
UBS Financial Services, Inc.
-
10 - 1 $

Holdings

NameEquities%Valuation
JW (CAYMAN) THERAPEUTICS CO. LTD
17.05%
 70,231,140 17.05% 19,118,321 $
AVIDITY BIOSCIENCES, INC.
6.85%
 5,075,304 6.85% 26,137,816 $
CELULARITY INC.
6.26%
 11,953,274 6.26% 2,617,767 $
COMPUGEN LTD.
5.39%
 4,757,058 5.39% 3,615,364 $
UNIQURE N.V.
5.00%
 2,388,108 5.00% 13,612,216 $

Company contact information

Bristol Myers Squibb Co.

345 Park Avenue

10154, New York

+212 546 4000

http://www.bms.com
address Bristol-Myers Squibb Company(BMY)

Group companies

NameCategory and Sector
Bristol-Myers Squibb Pharmaceuticals Ltd.
Health Technology - Pharmaceuticals: Major
Celgene Alpine Investment Co. LLC
-
Bristol-Myers Squibb SARL
Distribution Services - Medical Distributors
Bristol-Myers Squibb Holdings Ireland Unlimited Co.
-
Bristol-Myers Squibb Australia Pty Ltd.
Health Technology - Pharmaceuticals: Major
Bristol-Myers Squibb (Finland) Oy Ab
Health Technology - Pharmaceuticals: Generic
Bristol-Myers Squibb Belgium SA
Health Technology - Pharmaceuticals: Major
Bristol-Myers Squibb de México S de RL de CV
Health Technology - Pharmaceuticals: Major
Bristol-Myers Squibb AB
Distribution Services - Medical Distributors

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Bristol-Myers Squibb Company

Trading Rating :
Investor Rating :
ESG Refinitiv :
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
50.31USD
Average target price
64.13USD
Spread / Average Target
+27.48%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
BRISTOL-MYERS SQUIBB COMPANY Stock Bristol-Myers Squibb Company
-30.08% 102 B $
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+63.47% 538 B $
NOVO NORDISK A/S Stock Novo Nordisk A/S
+42.56% 430 B $
JOHNSON & JOHNSON Stock Johnson & Johnson
-12.58% 372 B $
ABBVIE INC. Stock AbbVie Inc.
-7.63% 264 B $
MERCK & CO., INC. Stock Merck & Co., Inc.
-6.49% 263 B $
ROCHE HOLDING AG Stock Roche Holding AG
-12.81% 232 B $
NOVARTIS AG Stock Novartis AG
+1.35% 198 B $
ASTRAZENECA PLC Stock AstraZeneca PLC
-9.77% 197 B $
PFIZER, INC. Stock Pfizer, Inc.
-43.83% 163 B $
Other Pharmaceuticals
  1. Stock
  2. Equities
  3. Stock Bristol-Myers Squibb Company - Nyse
  4. Company Bristol-Myers Squibb Company
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer